Gen-Probe Invests $50M into Pacific Biosciences | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market on Thursday that it has made a $50 million investment into sequencing firm Pacific Biosciences.

The Gen-Probe investment is part of a larger Series F private round of financing by PacBio, who is not disclosing the total amount for the round. As a result of the investment, Gen-Probe owns a 7 percent stake in PacBio.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.